Skip to main content
SpringerLink
Log in

T-cell depleted bone marrow transplantation for plasma cell myeloma

Report of a case and review of the results of BMT for myeloma

  • Short Communication
  • Published:
Blut Aims and scope Submit manuscript

Summary

A 37-year-old male patient with advanced refractory plasma cell myeloma underwent T-cell depleted bone marrow transplantation (BMT) after 7 years of active disease previously treated with combination chemotherapy and irradiation. After the BMT there was marked clinical improvement and the patient is currently in good clinical condition two years after the BMT was performed. However, residual myeloma cells are still seen in the marrow and stable levels of paraprotein are still present in the serum. No GVHD was encountered after BMT. The problems of BMT in myeloma are discussed with a review of the current pertinent literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alexanian R, Balcerzak S, Bonnet J, Gehan E, Haut A, Hewlett J, Monto R (1975) Prognostic factors in multiple myeloma. Cancer 16: 1192–1202

    Google Scholar 

  2. Barlogie B, Alexanian R, Dicke KA, Zagars G, Spitzer G, Jagannath S, Horwitz L (1987) High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 70: 869–872

    Google Scholar 

  3. Barlogie B, Hall R, Zander A, Dicke K, Alexanian R (1986) High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 67: 1298–1301

    Google Scholar 

  4. Bensinger WI, Buckner CD, Thomas ED, Clift RA (1982) ABO-incompatible marrow transplants. Transplantation 33: 427–429

    Google Scholar 

  5. Case DC Jr, Lee BJ, Clarkson BD (1977) Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol. Am J Med 63: 897–903

    Google Scholar 

  6. Dinota A, Tazzari PL, Grassi GP et al. (1986) Production and characterization of monoclonal antibodies for ex vivo purging of the bone marrow in patients with multiple myeloma. BMT 1 (Suppl 1): 309

    Google Scholar 

  7. Gahrton G, Ringden O, Lonnqvist B, Lindquist R, Ljungman P (1986) Bone marrow transplantation in three patients with multiple myeloma. Acta Med Scand 219: 523–527

    Google Scholar 

  8. Gahrton G, Tura S, Flesch M et al. (1987) Bone marrow transplantation in multiple myeloma: Report from the European Cooperative Group for Bone Marrow Transplantation. Blood 69: 1262

    Google Scholar 

  9. Higby DJ, Brass C, Fitzpatrick J, Henderson ES (1982) Bone marrow transplantation in multiple myeloma: A case report with protein studies. ASCO Abstracts 192: C-747

    Google Scholar 

  10. Kyle RA (1975) Multiple myeloma: Review of 869 cases. Mayo Clin Proc 50: 29

    Google Scholar 

  11. Kyle RA, Greipp PR, Gertz MA (1986) Treatment of refractory multiple myeloma and considerations for future therapy. Semin Oncol 13: 326

    Google Scholar 

  12. O'Reilly RJ (1982) Allogeneic bone marrow transplantation: Current status and future directions. Blood 62: 941–964

    Google Scholar 

  13. Osserman EF, DiRe LB, DiRe J, Sherman WH, Hersman JA, Storb R (1982) Identical twin marrow transplantation in multiple myeloma. Acta Hematol 68: 215

    Google Scholar 

  14. Ozer H, Han T, Nussbaum-Blumenson A, Henderson ES, Fitzpatrick J, Higby DJ (1984) Allogeneic bone marrow transplantation and idiotype monitoring in multiple myeloma. AACR Abstracts 25: 161

    Google Scholar 

  15. Slavin S, Waldmann H, Or R et al. (1985) Prevention of graft vs host disease in allogeneic bone marrow transplantation for leukemia by T cell depletion in vitro prior to transplantation. Transplant Proc 17: 465–467

    Google Scholar 

  16. Slavin S, Or R, Naparstek E et al. (1986) New approaches for prevention of rejection and graft vs host disease in clinical bone marrow transplantation. Isr J Med Sci 22: 264–267

    Google Scholar 

  17. Thomas ED (1983) Marrow transplantation for malignant diseases. J Clin Oncol 1: 517–530

    Google Scholar 

  18. Thomas ED (1985) High-dose therapy and bone marrow transplantation. Semin Oncol 12: 15–20

    Google Scholar 

  19. Tura S, Lucarelli G, Marmont A (1986) High-dose chemotherapy and BMT in the management of multiple myeloma: the Italian experience. BMT 1 (Suppl 1): 194

    Google Scholar 

  20. Tura S (1986) Bone marrow transplantation in multiple myeloma: Current status and future perspectives. BMT 1: 17–20

    Google Scholar 

  21. Waldmann H, Polliack A, Hale G et al. (1984) Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet II: 483–485

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine A, Hadassah University Hospital and Hebrew University Hadassah Medical School, IL-91120, Jerusalem, Israel

    A. Ben Yehuda

  2. Department of Bone Marrow Transplantation, Hadassah University Hospital and Hebrew University Hadassah Medical School, IL-91120, Jerusalem, Israel

    R. Or, E. Naparstek & S. Slavin

  3. Lymphoma Leukemia Unit, Department of Hematology, Hadassah University Hospital and Hebrew University Hadassah Medical School, IL-91120, Jerusalem, Israel

    A. Polliack

Authors
  1. A. Ben Yehuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Or
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Naparstek
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Slavin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Polliack
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yehuda, A.B., Or, R., Naparstek, E. et al. T-cell depleted bone marrow transplantation for plasma cell myeloma. Blut 56, 229–231 (1988). https://doi.org/10.1007/BF00320110

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00320110

Key words

Search

Navigation